Hyperthyroidism in pregnancy

The Lancet Diabetes and Endocrinology

Volumn 1, Issue 3, 2013, Pages 238-249

  Cooper, David S ^a   Laurberg, Peter ^b  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AALBORG UNIVERSITY HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHYROID AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CARBIMAZOLE; CHORIONIC GONADOTROPIN; DEXAMETHASONE; DIGOXIN; ESMOLOL; HYDROCORTISONE; LABETALOL; LIOTHYRONINE; METOPROLOL; PARACETAMOL; POTASSIUM IODIDE; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THYROTROPIN; THYROTROPIN RECEPTOR ANTIBODY; THYROXINE; THYROID HORMONE;

ADVERSE OUTCOME; AGRANULOCYTOSIS; ANCA ASSOCIATED VASCULITIS; ARTICLE; CHOLESTASIS; CONGENITAL MALFORMATION; CONGESTIVE HEART FAILURE; CONTINUOUS INFUSION; DRUG BLOOD LEVEL; DRUG CHOICE; DRUG FATALITY; DRUG MEGADOSE; DRUG MONITORING; EMBRYOPATHY; FETUS DEATH; FEVER; FIRST TRIMESTER PREGNANCY; FREE LIOTHYRONINE INDEX; FREE THYROXINE INDEX; GASTROINTESTINAL SYMPTOM; GRAVES DISEASE; HEART FAILURE; HUMAN; HYPEREMESIS GRAVIDARUM; HYPERPARATHYROIDISM; HYPERTHYROIDISM; LIVER INJURY; LIVER TOXICITY; LOW DRUG DOSE; PLACENTAL TRANSFER; POSTPARTUM THYROIDITIS; PREECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PREGNANT WOMAN; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PRURITUS; RASH; REMISSION; TACHYCARDIA; TERATOGENICITY; THYROID CRISIS; THYROID NODULE; THYROIDECTOMY; THYROTOXICOSIS; TOXIC GOITER; UNSPECIFIED SIDE EFFECT; BLOOD; COMPLICATION; FEMALE; FETAL DISEASES; NEWBORN;

ANTITHYROID AGENTS; FEMALE; FETAL DISEASES; GRAVES DISEASE; HUMANS; HYPERTHYROIDISM; INFANT, NEWBORN; PREGNANCY; THYROID HORMONES; THYROTROPIN;

EID: 84886929517     PISSN: 22138587     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-8587(13)70086-X     Document Type: Review

References (115)

1. Glinoer D The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status. Best Pract Res Clin Endocrinol Metab 2004, 18:133-152.
2. Huang SA, Dorfman DM, Genest DR, Salvatore D, Larsen PR Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium. J Clin Endocrinol Metab 2003, 88:1384-1388.
3. Laurberg P, Andersen SL, Pedersen IB, Andersen S, Carlé A Screening for overt thyroid disease in early pregnancy may be preferable to searching for small aberrations in thyroid function tests. Clin Endocrinol (Oxf) 2013, 79:297-304.
4. Stockigt JR Free thyroid hormone measurement. A critical appraisal. Endocrinol Metab Clin North Am 2001, 30:265-289.
5. Lee RH, Spencer CA, Mestman JH, et al. Free T4 immunoassays are flawed during pregnancy. Am J Obstet Gynecol 2009, 200:e1-e6.
6. Dashe JS, Casey BM, Wells CE, et al. Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges. Obstet Gynecol 2005, 106:753-757.
7. Lambert-Messerlian G, McClain M, Haddow JE, et al. First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study. Am J Obstet Gynecol 2008, 199:e1-e6. the FaSTER Research Consortium.
8. Rasmussen NG, Hornnes PJ, Hegedüs L Ultrasonographically determined thyroid size in pregnancy and post partum: the goitrogenic effect of pregnancy. Am J Obstet Gynecol 1989, 160:1216-1220.
9. Nelson M, Wickus GG, Caplan RH, Beguin EA Thyroid gland size in pregnancy. An ultrasound and clinical study. J Reprod Med 1987, 32:888-890.
10. Stagnaro-Green A, Abalovich M, Alexander E, et al. Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum. Thyroid 2011, 21:1081-1125. the American Thyroid Association Taskforce on Thyroid Disease During Pregnancy and Postpartum.
11. De Groot L, Abalovich M, Alexander EK, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012, 97:2543-2565.
12. Carlé A, Pedersen IB, Knudsen N, et al. Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study. Eur J Endocrinol 2011, 164:801-809.
13. Abraham-Nordling M, Byström K, Törring O, et al. Incidence of hyperthyroidism in Sweden. Eur J Endocrinol 2011, 165:899-905.
14. Laurberg P, Cerqueira C, Ovesen L, et al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract Res Clin Endocrinol Metab 2010, 24:13-27.
15. Amino N, Kuro R, Tanizawa O, et al. Changes of serum anti-thyroid antibodies during and after pregnancy in autoimmune thyroid diseases. Clin Exp Immunol 1978, 31:30-37.
16. Amino N, Tanizawa O, Mori H, et al. Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease. J Clin Endocrinol Metab 1982, 55:108-112.
17. Hershman JM Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid. Best Pract Res Clin Endocrinol Metab 2004, 18:249-265.
18. Rodien P, Brémont C, Sanson ML, et al. Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin. N Engl J Med 1998, 339:1823-1826.
19. Bolz M, Körber S, Schober HC TSH secreting adenoma of pituitary gland (TSHom)-rare cause of hyperthyroidism in pregnancy. Dtsch Med Wochenschr 2013, 138:362-366.
20. Paschke R, Niedziela M, Vaidya B, Persani L, Rapoport B, Leclere J 2012 European Thyroid Association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations. Eur Thyroid J 2012, 1:142-147.
21. Laurberg P, Berman DC, Bülow Pedersen I, Andersen S, Carlé A Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt. J Clin Endocrinol Metab 2012, 97:2325-2332.
22. Laurberg P, Vestergaard H, Nielsen S, et al. Sources of circulating 3,5,3'-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases. J Clin Endocrinol Metab 2007, 92:2149-2156.
23. Goldman AM, Mestman JH Transient non-autoimmune hyperthyroidism of early pregnancy. J Thyroid Res 2011, 2011:142413.
24. Casey BM, Dashe JS, Wells CE, McIntire DD, Leveno KJ, Cunningham FG Subclinical hyperthyroidism and pregnancy outcomes. Obstet Gynecol 2006, 107:337-341.
25. Davis LE, Lucas MJ, Hankins GD, Roark ML, Cunningham FG Thyrotoxicosis complicating pregnancy. Am J Obstet Gynecol 1989, 160:63-70.
26. Millar LK, Wing DA, Leung AS, Koonings PP, Montoro MN, Mestman JH Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism. Obstet Gynecol 1994, 84:946-949.
27. Sahu MT, Das V, Mittal S, Agarwal A, Sahu M Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome. Arch Gynecol Obstet 2010, 281:215-220.
28. Luewan S, Chakkabut P, Tongsong T Outcomes of pregnancy complicated with hyperthyroidism: a cohort study. Arch Gynecol Obstet 2011, 283:243-247.
29. Sheffield JS, Cunningham FG Thyrotoxicosis and heart failure that complicate pregnancy. Am J Obstet Gynecol 2004, 190:211-217.
30. Kriplani A, Buckshee K, Bhargava VL, Takkar D, Ammini AC Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy. Eur J Obstet Gynecol Reprod Biol 1994, 54:159-163.
31. Hamburger JI Diagnosis and management of Graves' disease in pregnancy. Thyroid 1992, 2:219-224.
32. McNab T, Ginsberg J Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves' disease. Clin Invest Med 2005, 28:127-131.
33. Smith C, Thomsett M, Choong C, Rodda C, McIntyre HD, Cotterill AM Congenital thyrotoxicosis in premature infants. Clin Endocrinol (Oxf) 2001, 54:371-376.
34. Luton D, Le Gac I, Vuillard E, et al. Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring. J Clin Endocrinol Metab 2005, 90:6093-6098.
35. Laurberg P, Bournaud C, Karmisholt J, Orgiazzi J Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy. Eur J Endocrinol 2009, 160:1-8.
36. Baloch Z, Carayon P, Conte-Devolx B, et al. Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease. Thyroid 2003, 13:3-126. the Guidelines Committee, National Academy of Clinical BiochemistryNational Academy of Clinical Biochemistry.
37. Haddow JE, McClain MR, Lambert-Messerlian G, et al. Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy. J Clin Endocrinol Metab 2008, 93:3341-3347. the First and Second Trimester Evaluation of Risk for Fetal Aneuploidy Research Consortium.
38. Glinoer D, de Nayer P, Bourdoux P, et al. Regulation of maternal thyroid during pregnancy. J Clin Endocrinol Metab 1990, 71:276-287.
39. Berta E, Samson L, Lenkey A, et al. Evaluation of the thyroid function of healthy pregnant women by five different hormone assays. Pharmazie 2010, 65:436-439.
40. Weeke J, Dybkjaer L, Granlie K, et al. A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy. Acta Endocrinol (Copenh) 1982, 101:531-537.
41. Barbesino G, Tomer Y Clinical utility of TSH receptor antibodies. J Clin Endocrinol Metab 2013, 98:2247-2255.
42. Laurberg P, Nygaard B, Glinoer D, Grussendorf M, Orgiazzi J Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association. Eur J Endocrinol 1998, 139:584-586.
43. Bahn Chair RS, Burch HB, Cooper DS, et al. Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 2011, 21:593-646. the American Thyroid Association, the American Association of Clinical Endocrinologiststhe American Association of Clinical Endocrinologists.
44. Kamijo K, Murayama H, Uzu T, Togashi K, Olivo PD, Kahaly GJ Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease. Thyroid 2011, 21:1295-1299.
45. Gardiner-Hill H Pregnancy complicating simple goiter and Graves' disease. Lancet 1952, 213:120-124.
46. Chapman EM, Corner GW, Robinson D, Evans RD The collection of radioactive iodine by the human fetal thyroid. J Clin Endocrinol Metab 1948, 8:717-720.
47. Astwood EB The use of antithyroid drugs during pregnancy. J Clin Endocrinol Metab 1951, 11:1045-1056.
48. Cooper DS Antithyroid drugs. N Engl J Med 2005, 352:905-917.
49. McGregor AM, Petersen MM, McLachlan SM, Rooke P, Smith BR, Hall R Carbimazole and the autoimmune response in Graves' disease. N Engl J Med 1980, 303:302-307.
50. Laurberg P Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism?. Eur J Endocrinol 2006, 155:783-786.
51. Marchant B, Brownlie BEW, Hart DM, Horton PW, Alexander WD The placental transfer of propylthiouracil, methimazole and carbimazole. J Clin Endocrinol Metab 1977, 45:1187-1193.
52. Mortimer RH, Cannell GR, Addison RS, Johnson LP, Roberts MS, Bernus I Methimazole and propylthiouracil equally cross the perfused human term placental lobule. J Clin Endocrinol Metab 1997, 82:3099-3102.
53. Gardner DF, Cruikshank DP, Hays PM, Cooper DS Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests. J Clin Endocrinol Metab 1986, 62:217-220.
54. Momotani N, Noh JY, Ishikawa N, Ito K Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism. J Clin Endocrinol Metab 1997, 82:3633-3636.
55. Wing DA, Millar LK, Koonings PP, Montoro MN, Mestman JH A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol 1994, 170:90-95.
56. Homsanit M, Sriussadaporn S, Vannasaeng S, Peerapatdit T, Nitiyanant W, Vichayanrat A Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism. Clin Endocrinol (Oxf) 2001, 54:385-390.
57. Momotani N, Noh J, Oyanagi H, Ishikawa N, Ito K Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status. N Engl J Med 1986, 315:24-28.
58. Bliddal S, Rasmussen AK, Sundberg K, Brocks V, Feldt-Rasmussen U Antithyroid drug-induced fetal goitrous hypothyroidism. Nat Rev Endocrinol 2011, 7:396-406.
59. Messer PM, Hauffa BP, Olbricht T, Benker G, Kotulla P, Reinwein D Antithyroid drug treatment of Graves' disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring. Acta Endocrinol (Copenh) 1990, 123:311-316.
60. Eisenstein Z, Weiss M, Katz Y, Bank H Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero. Eur J Pediatr 1992, 151:558-559.
61. Taylor PN, Vaidya B Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy. Eur Thyroid J 2012, 1:176-185.
62. Takata K, Kubota S, Fukata S, et al. Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily. Thyroid 2009, 19:559-563.
63. Glinoer D, Cooper DS The propylthiouracil dilemma. Curr Opin Endocrinol Diabetes Obes 2012, 19:402-407.
64. Cooper DS, Rivkees SA Putting propylthiouracil in perspective. J Clin Endocrinol Metab 2009, 94:1881-1882.
65. Burch HB, Burman KD, Cooper DSA A 2011 survey of clinical practice patterns in the management of Graves' disease. J Clin Endocrinol Metab 2012, 97:4549-4558.
66. Emiliano AB, Governale L, Parks M, Cooper DS Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008. J Clin Endocrinol Metab 2010, 95:2227-2233.
67. Foulds N, Walpole I, Elmslie F, Mansour S Carbimazole embryopathy: an emerging phenotype. Am J Med Genet A 2005, 132A:130-135.
68. Yoshihara A, Noh J, Yamaguchi T, et al. Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation. J Clin Endocrinol Metab 2012, 97:2396-2403.
69. Korelitz JJ, McNally DL, Masters MN, Li SX, Xu Y, Rivkees S Prevalence of thyrotoxicosis, anti-thyroid medication use, and complications among pregnant women in the United States. Thyroid 2012, 23:758-765.
70. Chen CH, Xirasagar S, Lin CC, Wang LH, Kou YR, Lin HC Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study. BJOG 2011, 118:1365-1373.
71. FDA Drug Safety Communication: New Boxed Warning on severe liver injury with propylthiouracil US Food and Drug Administration, (accessed Jan 4, 2013). http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/ucm209023.htm.
72. Negro R, Beck-Peccoz P, Chiovato L, et al. Hyperthyroidism and pregnancy. An Italian Thyroid Association (AIT) and Italian Association of Clinical Endocrinologists (AME) joint statement for clinical practice. J Endocrinol Invest 2011, 34:225-231.
73. Wood LC, Maloof F Thyroid failure after potassium iodide treatment of diffuse toxic goiter. Trans Assoc Am Physicians 1975, 88:235-247.
74. Connelly KJ, Boston BA, Pearce EN, et al. Congenital hypothyroidism caused by excess prenatal maternal iodine ingestion. J Pediatr 2012, 161:760-762.
75. Momotani N, Hisaoka T, Noh J, Ishikawa N, Ito K Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy. J Clin Endocrinol Metab 1992, 75:738-744.
76. Magee LA, Duley L Oral beta-blockers for mild to moderate hypertension during pregnancy. Cochrane Database Syst Rev 2003, 3. CD002863.
77. Meidahl Petersen K, Jimenez-Solem E, Andersen JT, et al. β-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study. BMJ Open 2012, 2:e001185.
78. Rubin PC Current concepts: beta-blockers in pregnancy. N Engl J Med 1981, 305:1323-1326.
79. Frishman WH, Chesner M Beta-adrenergic blockers in pregnancy. Am Heart J 1988, 115:147-152.
80. Sherif IH, Oyan WT, Bosairi S, Carrascal SM Treatment of hyperthyroidism in pregnancy. Acta Obstet Gynecol Scand 1991, 70:461-463.
81. Bowman ML, Bergmann M, Smith JF Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis. Thyroid 1998, 8:795-796.
82. Kuy S, Roman SA, Desai R, Sosa JA Outcomes following thyroid and parathyroid surgery in pregnant women. Arch Surg 2009, 144:399-406. discussion 406.
83. Erbil Y, Ozluk Y, Giriş M, et al. Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease. J Clin Endocrinol Metab 2007, 92:2182-2189.
84. Chan GW, Mandel SJ Therapy insight: management of Graves' disease during pregnancy. Nat Clin Pract Endocrinol Metab 2007, 3:470-478.
85. Mestman JH Hyperthyroidism in pregnancy. Best Pract Res Clin Endocrinol Metab 2004, 18:267-288.
86. Westgren U, Ahrén B, Burger A, Ingemansson S, Melander A Effects of dexamethasone, desoxycorticosterone, and ACTH on serum concentrations of thyroxine, 3,5,3'-triiodothyronine and 3,3',5'-triiodothyronine. Acta Med Scand 1977, 202:89-92.
87. Rotondi M, Cappelli C, Pirali B, et al. The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy. J Clin Endocrinol Metab 2008, 93:3985-3988.
88. Jansson R, Dahlberg PA, Winsa B, Meirik O, Säfwenberg J, Karlsson A The postpartum period constitutes an important risk for the development of clinical Graves' disease in young women. Acta Endocrinol (Copenh) 1987, 116:321-325.
89. Tada H, Hidaka Y, Tsuruta E, et al. Prevalence of postpartum onset of disease within patients with Graves' disease of child-bearing age. Endocr J 1994, 41:325-327.
90. Benhaim Rochester D, Davies TF Increased risk of Graves' disease after pregnancy. Thyroid 2005, 15:1287-1290.
91. Rotondi M, Pirali B, Lodigiani S, et al. The post partum period and the onset of Graves' disease: an overestimated risk factor. Eur J Endocrinol 2008, 159:161-165.
92. Nakagawa Y, Mori K, Hoshikawa S, Yamamoto M, Ito S, Yoshida K Postpartum recurrence of Graves' hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy. Clin Endocrinol (Oxf) 2002, 57:467-471.
93. Johansen K, Andersen AN, Kampmann JP, Mølholm Hansen JM, Mortensen HB Excretion of methimazole in human milk. Eur J Clin Pharmacol 1982, 23:339-341.
94. Cooper DS, Bode HH, Nath B, Saxe V, Maloof F, Ridgway EC Methimazole pharmacology in man: studies using a newly developed radioimmunoassay for methimazole. J Clin Endocrinol Metab 1984, 58:473-479.
95. Momotani N, Yamashita R, Makino F, Noh JY, Ishikawa N, Ito K Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil. Clin Endocrinol (Oxf) 2000, 53:177-181.
96. Azizi F, Khoshniat M, Bahrainian M, Hedayati M Thyroid function and intellectual development of infants nursed by mothers taking methimazole. J Clin Endocrinol Metab 2000, 85:3233-3238.
97. Transfer of drugs and other chemicals into human milk. Pediatrics 2001, 108:776-789. American Academy of Pediatrics Committee on Drugs.
98. Mortimer RH, Tyack SA, Galligan JP, Perry-Keene DA, Tan YM Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function. Clin Endocrinol (Oxf) 1990, 32:141-152.
99. Cove DH, Johnston P Fetal hyperthyroidism: experience of treatment in four siblings. Lancet 1985, 1:430-432.
100. Houck JA, Davis RE, Sharma HM Thyroid-stimulating immunoglobulin as a cause of recurrent intrauterine fetal death. Obstet Gynecol 1988, 71:1018-1019.
101. Treadwell MC, Sherer DM, Sacks AJ, Ghezzi F, Romero R Successful treatment of recurrent non-immune hydrops secondary to fetal hyperthyroidism. Obstet Gynecol 1996, 87:838-840.
102. Zimmerman D Fetal and neonatal hyperthyroidism. Thyroid 1999, 9:727-733.
103. Polak M, Van Vliet G Therapeutic approach of fetal thyroid disorders. Horm Res Paediatr 2010, 74:1-5.
104. Thorpe-Beeston JG, Nicolaides KH, McGregor AM Fetal thyroid function. Thyroid 1992, 2:207-217.
105. Hume R, Simpson J, Delahunty C, et al. Human fetal and cord serum thyroid hormones: developmental trends and interrelationships. J Clin Endocrinol Metab 2004, 89:4097-4103. the Scottish Preterm Thyroid Group.
106. Weiss RE, Dumitrescu A, Refetoff S Approach to the patient with resistance to thyroid hormone and pregnancy. J Clin Endocrinol Metab 2010, 95:3094-3102.
107. Anselmo J, Cao D, Karrison T, Weiss RE, Refetoff S Fetal loss associated with excess thyroid hormone exposure. JAMA 2004, 292:691-695.
108. Matsuura N, Harada S, Ohyama Y, et al. The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease. Pediatr Res 1997, 42:214-218.
109. Kempers MJ, van Trotsenburg AS, van Rijn RR, et al. Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease. J Clin Endocrinol Metab 2007, 92:2984-2991.
110. Amino N, Tada H, Hidaka Y Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease. Thyroid 1999, 9:705-713.
111. Stagnaro-Green A Postpartum thyroiditis. Best Pract Res Clin Endocrinol Metab 2004, 18:303-316.
112. Lazarus JH, Parkes AB, Premawardhana LD Postpartum thyroiditis. Autoimmunity 2002, 35:169-173.
113. Nøhr SB, Jørgensen A, Pedersen KM, Laurberg P Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe?. J Clin Endocrinol Metab 2000, 85:3191-3198.
114. Stagnaro-Green A, Schwartz A, Gismondi R, Tinelli A, Mangieri T, Negro R High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy. J Clin Endocrinol Metab 2011, 96:652-657.
115. Premawardhana LD, Parkes AB, Ammari F, et al. Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity. J Clin Endocrinol Metab 2000, 85:71-75.